Oud Lavi, Garza John
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX, USA.
Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX, USA.
Acute Crit Care. 2022 Nov;37(4):533-542. doi: 10.4266/acc.2022.00787. Epub 2022 Oct 6.
Rheumatoid arthritis (RA) is associated with increased risk of sepsis and higher infection-related mortality compared to the general population. However, the evidence on the prognostic impact of RA in sepsis has been inconclusive. We aimed to estimate the population-level association of RA with short-term mortality in sepsis.
We used statewide data to identify hospitalizations aged ≥18 years in Texas with sepsis, with and without RA during 2014-2017. Hierarchical logistic models with propensity adjustment (primary model), propensity score matching, and multivariable logistic regression without propensity adjustment were used to estimate the association of RA with short-term mortality among sepsis hospitalizations.
Among 283,025 sepsis hospitalizations, 7,689 (2.7%) had RA. Compared to sepsis hospitalizations without RA, those with RA were older (aged ≥65 years, 63.9% vs. 56.4%) and had higher burden of comorbidities (mean Deyo comorbidity index, 3.2 vs. 2.7). Short-term mortality of sepsis hospitalizations with and without RA was 26.8% vs. 31.4%. Following adjustment for confounders, short-term mortality was lower among RA patients (adjusted odds ratio [aOR], 0.910; 95% confidence interval [CI], 0.856-0.967), with similar findings on alternative models. On sensitivity analyses, short-term mortality was lower in RA patients among sepsis hospitalizations aged ≥65 years and those with septic shock, but not among those admitted to intensive care unit (ICU; aOR, 0.990; 95% CI, 0.909-1.079).
RA was associated, unexpectedly, with lower short-term mortality in septic patients. However, this "protective" association was driven by those patients without ICU admission. Further studies are warranted to confirm these findings and to examine the underlying mechanisms.
与普通人群相比,类风湿关节炎(RA)患者发生脓毒症的风险增加,且感染相关死亡率更高。然而,关于RA对脓毒症预后影响的证据尚无定论。我们旨在评估在人群水平上RA与脓毒症短期死亡率之间的关联。
我们利用德克萨斯州全州范围的数据,确定了2014 - 2017年间年龄≥18岁的脓毒症住院患者,包括伴有和不伴有RA的患者。采用带有倾向得分调整的分层逻辑模型(主要模型)、倾向得分匹配以及无倾向得分调整的多变量逻辑回归,来评估RA与脓毒症住院患者短期死亡率之间的关联。
在283,025例脓毒症住院患者中,7689例(2.7%)患有RA。与无RA的脓毒症住院患者相比,患有RA的患者年龄更大(≥65岁者,63.9%对56.4%),且合并症负担更重(平均Deyo合并症指数,3.2对2.7)。伴有和不伴有RA的脓毒症住院患者的短期死亡率分别为26.8%和31.4%。在对混杂因素进行调整后,RA患者的短期死亡率较低(调整后的比值比[aOR]为0.910;95%置信区间[CI]为0.856 - 0.967),在其他模型中也有类似发现。在敏感性分析中,年龄≥65岁的脓毒症住院患者以及发生感染性休克的患者中,RA患者的短期死亡率较低,但在入住重症监护病房(ICU)的患者中并非如此(aOR为0.990;95%CI为0.909 - 1.079)。
出乎意料的是,RA与脓毒症患者较低的短期死亡率相关。然而,这种“保护”性关联是由未入住ICU的患者驱动的。有必要进行进一步研究以证实这些发现并探究其潜在机制。